Montevisin, eye drops 0.05%, 10 ml

Alpha-adrenomimetic.

Alpha-adrenomimetic, imidazole derivative, has vasoconstrictor and anticongestive effect.

Vasoconstrictor effect without secondary reactive hyperemia develops within a few minutes and lasts 4-8 h.

Indications

Active ingredient

Composition

1 ml of the solution contains:

The active ingredient:

Tetrizolin hydrochloride 0.5 mg;

Associates:

Benzalkonium chloride 0.1 mg,

Dinatrium edetate dihydrate 1.0 mg,

Sodium chloride 1.80 mg,

How to take, the dosage

Topically. 1-2 drops in each conjunctival sac 2-3 times a day.

If there is no improvement within 48 hours, further use should be discontinued and a physician consulted.

Interaction

Incompatible with MAO inhibitors, tricyclic antidepressants, maprotiline (possibility of hypertensive crisis), inhalation anesthetics (e.g., cyclopropane, halothane and other halogenated anesthetics that can cause ventricular fibrillation).

Special Instructions

Use for 28 days after opening the bottle.

Long-term use and overdose should be avoided, especially in children.

If the eye condition is not an obstacle to wearing contact lenses, these should be removed before putting the medication in and inserted after about 15 minutes.

Please avoid direct contact between the eye drops and soft contact lenses due to the risk of blurring their transparency.

If the condition does not improve within 48 hours or if irritation and eye hyperemia persist or increase, discontinue the product and consult a physician.

If intense eye pain, headache, vision loss, sudden flickers, red eyes, pain on exposure to light, or double vision occur, a physician should be seen immediately.

If the patient has blurred vision after using the drug, it is not recommended to drive or engage in activities requiring increased attention until it is restored.

Synopsis

Features

Contraindications

Hypersensitivity to the components of the drug, glaucoma, children under 2 years of age, endothelial-epithelial dystrophy of the cornea.

With caution

Artial hypertension, arrhythmias, aneurysm, thyrotoxicosis, pheochromocytoma, diabetes mellitus, severe organic heart and vascular disease (includingincluding coronary heart disease); the period of treatment with monoamine oxidase inhibitors (MAOIs) and other drugs that increase blood pressure.

Side effects

Overdose

Symptoms:

Mydriasis, cyanosis, fever, seizures, arrhythmias, increased blood pressure, pulmonary edema, dyspnea, cardiac arrest.

The excessive total absorption of imidazole derivatives may lead to central nervous system depression accompanied by somnolence, hypothermia, bradycardia, collapse, apnea, and coma.

The risk of overdose symptoms associated with drug absorption is high in young children, especially if swallowed.

Treatment:

The antidote is unknown. Activated charcoal, gastric lavage, oxygen inhalation, antipyretic and anti-epileptic agents are prescribed.

To reduce blood pressure, phentholamine 5 mg on saline slowly v/v or 100 mg orally.

Pregnancy use

The drug may be used during pregnancy and breastfeeding if the expected benefits to the mother exceed the potential risk to the fetus and child

Similarities